The benzodiazepine antagonist Ro 15–1788 reverses the effect of methyl-β-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice
- 1 February 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 109 (2) , 241-247
- https://doi.org/10.1016/0014-2999(85)90425-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Contrasting effects of ethyl β-carboline-3-carboxylate (βCCE) and diazepam on cerebellar cyclic GMP content and antagonism of both effects by Ro 15-1788, a specific benzodiazepine receptor blockerEuropean Journal of Pharmacology, 1983
- Ethyl β-carboline-3-carboxylate reverses the diazepam effect on cerebellar cyclic GMPEuropean Journal of Pharmacology, 1982
- Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effectsPsychopharmacology, 1982
- Selective antagonists of benzodiazepinesNature, 1981
- Brain nucleotides in naive and handling-habituated rats: differences in levels and drug-sensitivityBrain Research, 1980
- Circadian Rhythm of Cyclic Nucleotide and GAB A Levels in the Rat BrainPharmacology, 1979
- Harmaline and its sulfur analogue: Increase of cerebellar cyclic GMP and inhibition of monoamine oxidaseBiochemical Pharmacology, 1977
- Stress-induced alterations of cyclic nucleotide levels in brain: Effects of centrally acting drugsPsychopharmacology, 1977
- Effect of desmethyldiazepam and chlordesmethyldiazepam on 3?,5?-cyclic guanosine monophosphate levels in rat cerebellumPsychopharmacology, 1976
- Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphologyNeuropharmacology, 1974